ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model.
Dianyu CaoJina ZhengZheng LiYong YuZengrui ChenQiang WangPublished in: Arthritis research & therapy (2023)
ACSL4 induces inflammatory macrophage ferroptosis to aggravate fibrosis progressing. ACSL4 and its upregulators of calpains may be potential therapeutic targets for BLM model of SSc.